In these GO categories, genes such as PHLDA1, SATB2, ROBO2, LEF1, MYO10 and integrin, alpha V (ITGAV) were predicted as novel prognostic or diagnostic biomarkers and new therapeutic target in CAD. Here, LEF1 is linked to coronary artery disorder.